09960.HK
Kindstar Globalgene Technology, Inc.
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 0.95
−1.56%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9B | 933.6M | 927.6M | 967.3M | 1.4B |
| Cost of Revenue | 1.0B | 522.2M | 488.0M | 516.1M | 783.5M |
| Gross Profit | 843.2M | 411.4M | 439.6M | 451.1M | 603.1M |
| Operating Expenses | |||||
| R&D Expense | 198.2M | 95.9M | 105.8M | 105.3M | 101.2M |
| SG&A Expense | 817.7M | 426.5M | 382.4M | 413.4M | 441.0M |
| General & Admin Expense | 226.3M | 118.4M | 100.3M | 105.6M | 80.4M |
| Selling & Marketing Expense | 591.4M | 308.2M | 282.2M | 307.8M | 360.6M |
| Other Expenses | — | — | (12.3M) | (25.1M) | (9.7M) |
| Total Operating Expenses | 1.0B | 522.4M | 475.9M | 493.6M | 532.5M |
| Cost and Expenses | 2.0B | 1.0B | 972.9M | 1.0B | 1.3B |
| Operating Income (EBIT) | (172.7M) | (111.0M) | (45.3M) | (42.5M) | 70.6M |
| Non-Operating | |||||
| Interest Income | 144.7M | 63.0M | 82.4M | 82.8M | 51.3M |
| Interest Expense | 16.7M | 14.9M | 11.1M | 8.0M | 2.5M |
| Net Interest Income | 83.4M | 48.1M | 68.7M | 74.8M | 48.8M |
| Other Non-Op Income/Expense | 46.2M | 70.6M | (10.9M) | 85.8M | 12.8M |
| Non-Operating Income (excl Interest) | 178.0M | 63.7M | 118.7M | (93.8M) | (15.3M) |
| EBT (Pre-Tax Income) | (126.5M) | (40.4M) | (56.2M) | 43.3M | 83.3M |
| Income Tax Expense | 17.8M | 14.8M | 4.5M | 6.9M | 5.8M |
| Bottom Line | |||||
| Net Income | (144.1M) | (58.7M) | (54.6M) | 41.3M | 75.5M |
| Earnings from Cont. Ops | (144.4M) | (55.1M) | (60.7M) | 36.4M | 77.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (144.1M) | (58.7M) | (54.6M) | 41.3M | 75.5M |
| Per Share | |||||
| Basic EPS | (HK$0.15) | (HK$0.06) | (HK$0.06) | HK$0.04 | HK$0.09 |
| Diluted EPS | (HK$0.15) | (HK$0.06) | (HK$0.06) | HK$0.04 | HK$0.09 |
| Revenue Per Share | HK$1.87 | HK$0.94 | HK$0.98 | HK$1.00 | HK$1.70 |
| Shares | |||||
| Basic Shares Outstanding | 997.1M | 992.3M | 946.1M | 970.8M | 818.0M |
| Diluted Shares Outstanding | 997.1M | 992.7M | 946.2M | 970.8M | 818.0M |
| Profitability Metrics | |||||
| EBITDA | (207.0M) | (95.7M) | (117.2M) | 126.4M | 150.7M |
| D&A | 143.7M | 79.0M | 46.8M | 75.0M | 64.9M |
| EBIT | (350.7M) | (174.7M) | (164.0M) | 51.4M | 85.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026